Controlant
Real-time IoT monitoring devices, analytics and cloud software for pharma and life-sciences cold-chain shipments, sold to drugmakers, 4PLs and logistics providers.
Controlant sells connected data-logging devices, a cloud visibility platform, predictive analytics and 24/7 monitoring services. Together these track temperature and other conditions in temperature-sensitive pharmaceutical shipments from production through distribution. Customers include pharmaceutical manufacturers, CMOs and 4PLs. It is a privately held company, backed by investors including Frumtak, Sjóvá, VIS and Apax Credit Funds. Funding includes a $15M Series B in 2020 and about €37.4M from Apax Credit Funds in 2023. Tracxn lists a later round in November 2024 and puts total funding near $92.5M. In 2020 it worked with Pfizer on COVID-19 vaccine supply-chain monitoring. Employee counts vary by source, with about 209 reported for mid-2026. Revenue is not published, and third-party estimates range widely.
